79 YEARS OF GALENIKA: GROWTH IS THE SUCCESS OF ALL EMPLOYEES
Belgrade, September 24, 2024 – In the year when it marks 79 years of leadership in the pharmaceutical industry, Galenika continues with constant growth through a significant expansion of its product portfolio and further internationalization. In the first 7 months of 2024, Galenika registered as many as 90 products in Serbia and regional markets, as well as increased total production by 18% compared to the same period last year. On the Serbian market, Galenika achieved an 18 percent increase in sales, while sales in the EU more than doubled. In addition to Serbia, Galenika successfully operates in 25 international markets, and plans to expand to 10 more markets in Europe and the MENA region.
Galenika has 40 brands in leading positions in their categories by market share in Serbia, while in partnership with EMS – the largest pharmaceutical company in Brazil, Galenika successfully implemented technology transfer for 6 more products in the first 7 months.
“This year we celebrate 79 years, we record constant growth, our products are available on three continents – and this is the success of the whole team. Users of our products know the brand and know that Galenika is a guarantee of top quality. We strive to continuously change people’s lives for the better, through research and development, education, technology, networking and investments. All employees who work in Galenika today, and those who worked in the past, contributed to its growth and importance. Times are changing, but our people are and will be our strength,” said Ricardo Vian Marques, General Manager of Galenika.
Galenika is permanently focused on the education of its employees and partners, as well as on a responsible and sustainable way of doing business as one of the pillars that drive development. In the first 7 months, total number of hours invested in employee training was almost tripled, and the company organized and sponsored 49 professional medical events for around 1,000 healthcare workers from Serbia. As a result of the investment in the renovation of the internal water supply system, in the first 7 months Galenika reduced its water consumption by more than double compared to the same period last year. In addition, from January to July, Galenika realized donations of medical equipment for two health institutions as well as donations of medicines for 44 health institutions in Serbia.
Galenika pharmaceutical company was founded in 1945.After privatization in November 2017, it became part of the NC Group (www.gruponc.net.br), which includes EMS – the largest pharmaceutical company in Brazil and one of the largest pharma companies in the whole of Latin America. Galenika produces generic drugs, dietary supplements, cosmetic products, medical devices and general use products. The strategy of the Group is the development of Galenika as a modern and flexible company, focused on research and development, which is constantly working to improve its products for improving health and quality of life, to the satisfaction of consumers.
Leave a reply